Preliminary report of preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates, SK-01 version 1 and OZG-3861 version 1
G. SIR KARAKUS, C. Tastan, D. Dilek Kancagi, B. Yurtsever, G. Tumentemur, S. Demir, R. D. Turan, S. Abanuz, D. Cakirsoy, U. Seyis, S. Ozer, O. Elibol, M. Elek, G. Ertop, S. Arbak, , E. Ovali
This study evaluates the safety and immunogenicity of two gamma-irradiated inactivated SARS-CoV-2 vaccines in mice, showing significant antibody and T cell responses without antibody-dependent enhancement.
bioRxiv · Sep 4, 2020 · PreprintImmunology